Show simple item record

dc.contributor.authorSestak, Ien_US
dc.contributor.authorSmith, SGen_US
dc.contributor.authorHowell, Aen_US
dc.contributor.authorForbes, JFen_US
dc.contributor.authorCuzick, Jen_US
dc.date.accessioned2018-02-06T15:23:49Z
dc.date.available2017-10-23en_US
dc.date.issued2018-02en_US
dc.date.submitted2017-12-20T11:00:18.255Z
dc.identifier.issn0923-7534en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/32064
dc.description.sponsorshipCancer Research UK (C569/A5032 to JC, C42785/A17965 to SGS); and AstraZeneca (no grant number applies).en_US
dc.format.extent504 - 509en_US
dc.language.isoenen_US
dc.relation.ispartofANNALS OF ONCOLOGYen_US
dc.rightsThis is a pre-copyedited, author-produced version of an article accepted for publication in journal of Annals of Oncology, following peer review. The version of record I Sestak, S G Smith, A Howell, J F Forbes, J Cuzick; Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II, Annals of Oncology is available online at https://doi.org/10.1093/annonc/mdx713
dc.subjectbreast canceren_US
dc.subjectpreventionen_US
dc.subjectadherenceen_US
dc.subjectendocrine therapyen_US
dc.titleEarly participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies IIen_US
dc.typeArticle
dc.rights.holder(c) The Author(s) 2017.
dc.identifier.doi10.1093/annonc/mdx713en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425503100034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue2en_US
pubs.notes12 monthsen_US
pubs.publication-statusPublisheden_US
pubs.volume29en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record